Search research articles
Contact Us
Filters
Showing results (511-520 of 648) with videos related to
Page
of 65
Sort By:
Eclinicalmedicine
|
April 17, 2025
Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial
FangJie Liu, DaQuan Wang, YuMing Rong, et al.
Clinical and Translational Radiation Oncology
|
March 13, 2023
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases
Shouliang Ding, Biaoshui Liu, Shiyang Zheng, et al.
Eclinicalmedicine
|
April 24, 2026
Fraction dose escalation of split-course concurrent chemoradiotherapy following induction chemo-immunotherapy in unresectable locally advanced oesophageal squamous carcinoma in China (GASTO-10102): a single-centre phase 1 study
FangJie Liu, DaQuan Wang, GuangYu Luo, et al.
Biomedical Chromatography : BMC
|
June 17, 2017
Simultaneous quantification of imatinib and its main metabolite N-demethyl-imatinib in human plasma by liquid chromatography-tandem mass spectrometry and its application to therapeutic drug monitoring in patients with gastrointestinal stromal tumor
Wei Zhuang, Hai-Bo Qiu, Xin-Meng Chen, et al.
Frontiers in Oncology
|
October 24, 2022
Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies
FanJun Meng, XinLei Ai, Bin Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 18, 2005
Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5
Xin-Yuan Liu, Song-Bo Qiu, Wei-Gou Zou, et al.
Nature Communications
|
June 30, 2021
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
Shiliang Liu, Liling Luo, Lei Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 29, 2022
Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer
Bo Qiu, Yu Xi, FangJie Liu, et al.
World Journal of Gastroenterology
|
December 16, 2010
Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma
Wei Wang, Guo-Qiang Wang, Xiao-Wei Sun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2023
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)
Rui Zhou, Bo Qiu, Mai Xiong, et al.
Page
of 65
Search research articles
Search
Showing results (511-520 of 648) with videos related to
Sort By:
Page
of 65
Eclinicalmedicine
|
April 17, 2025
Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial
FangJie Liu, DaQuan Wang, YuMing Rong, et al.
Clinical and Translational Radiation Oncology
|
March 13, 2023
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases
Shouliang Ding, Biaoshui Liu, Shiyang Zheng, et al.
Eclinicalmedicine
|
April 24, 2026
Fraction dose escalation of split-course concurrent chemoradiotherapy following induction chemo-immunotherapy in unresectable locally advanced oesophageal squamous carcinoma in China (GASTO-10102): a single-centre phase 1 study
FangJie Liu, DaQuan Wang, GuangYu Luo, et al.
Biomedical Chromatography : BMC
|
June 17, 2017
Simultaneous quantification of imatinib and its main metabolite N-demethyl-imatinib in human plasma by liquid chromatography-tandem mass spectrometry and its application to therapeutic drug monitoring in patients with gastrointestinal stromal tumor
Wei Zhuang, Hai-Bo Qiu, Xin-Meng Chen, et al.
Frontiers in Oncology
|
October 24, 2022
Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies
FanJun Meng, XinLei Ai, Bin Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 18, 2005
Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5
Xin-Yuan Liu, Song-Bo Qiu, Wei-Gou Zou, et al.
Nature Communications
|
June 30, 2021
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
Shiliang Liu, Liling Luo, Lei Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 29, 2022
Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer
Bo Qiu, Yu Xi, FangJie Liu, et al.
World Journal of Gastroenterology
|
December 16, 2010
Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma
Wei Wang, Guo-Qiang Wang, Xiao-Wei Sun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2023
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)
Rui Zhou, Bo Qiu, Mai Xiong, et al.
Page
of 65